Best Agrolife Limited has informed the Exchange about General Updates
BESTAGRO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Best Agrolife filed its Q1 FY26 corporate presentation, reporting revenue of ₹381 crore, down 27% YoY from ₹519 crore, as management deliberately shifted away from early-season product placements to focus on in-season sales and inventory discipline. Despite the topline dip, profitability improved: gross margin rose to 29% (from 25%), EBITDA margin to 12% (up 150 bps), and PAT margin to 5%, with PAT holding flat at ₹20 crore. Sequentially vs Q4 FY25, revenue grew 39% and EBITDA surged 952% from a low base. New patented products Shot Down, Best Man, and Fetagen performed strongly in their debut season, collectively covering over 5 lakh acres. Patented products' share of branded sales jumped to 45% from 29%, and branded sales rose to 65% of total mix.
The revenue decline is a strategic choice rather than weakness — management is prioritizing margin expansion, lower sales returns, and leaner inventory over headline growth. Improving margins and a stronger branded/patented mix support a quality-of-earnings story, though near-term topline softness may cap upside until seasonal momentum builds.